The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...
23h
Stockhead on MSNLevel achieved: Orthocell gains FDA approval for flagship nerve repair productOrthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...
Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.
Sweeping job cuts and reorganizations taking place at the US Department of Health and Human Services under Secretary Robert F ...
ORA’s Thakur, DHA R&D-MRDC’s 2024 employee of the year, speeds lifesaving devices to warfighters
Dr. Chandar Thakur, chief of the Medical Devices and Diagnostics Branch at DHA R&D-MRDC’s Office of Regulated Activities, is the 2024 Employee of the Year.
The General Directorate of Drugs, Food, and Health Products (Digemaps) issued a public warning about unapproved weight-loss ...
Ask any smoker who has tried to quit and they’ll tell you it isn’t easy. But a recent study offers a surprising glimmer of ...
Finding the best weight loss supplements for women (or anyone, really) can be like finding a needle in a haystack — except ...
11h
Zacks Investment Research on MSNPharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits FailureThis week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of ...
While manufacturers of FDA-approved injectable pentobarbital are warning states not to use the sedative in executions, some states are still buying it — and paying top dollar.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results